By: Scot Ackerman, M.D. -- Immigrants to the U.S. often develop an increased risk of colon cancer. To discover the reason behind this phenomenon, Pennsylvania researchers compared the diets of 20 black Americans residing in the Pittsburgh area to the diet of 20 black South Africans.
By: Karen Ambrosio, Oncology Wellness Specialist -- In general, sarcopenia may increase a cancer patient’s risk of adverse outcomes, such as physical disability or becoming bedridden. The resulting poor quality of life is a factor for increased mortality rates. In fact, cancer patients with sarcopenia are more prone to severe toxicity during chemotherapy, which can require reduced dosages and potential treatment delays that may ultimately reduce treatment efficacy.
By: Alan Forbes, M.D., Ph.D. -- Recently, researchers at UT Southwestern Medical Center’s Kidney Cancer Program successfully used SBRT to treat inferior vena cava tumor thrombus (IVC-TT), a sometimes deadly complication of kidney cancer.
Many patients undergoing cancer treatment experience fatigue. Unlike tiredness, which usually goes away with a good night’s sleep, fatigue is a persistent lack of energy or weakness that does not improve with rest. The fatigue may last only a short time, or it may continue beyond treatment. The following suggestions may help combat fatigue.